In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening ...
Powles Highlights “Transformative” Benefit of EV Plus Pembro While Sharing Long-Term Data for EV-302
The lead investigator for EV-302 said not long ago, survival of 12 to 14 months in this type of bladder cancer was considered ...
Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results